This bill establishes new provisions under the Arkansas Medicaid Program regarding the administration of immunizations and monoclonal antibodies for respiratory syncytial virus (RSV) disease. It introduces a new section, 20-77-408, which mandates that the Arkansas Medicaid Program reimburse an administration fee equal to 100% of the maximum fee set by the Vaccines for Children Program for administering these treatments to infants and toddlers. The bill clarifies that hospitals are not required to provide additional services related to these immunizations and that the Department of Human Services must seek any necessary federal waivers or amendments to implement these changes.

Additionally, the bill adds a new section, 16-114-214, which provides civil immunity to individuals or entities involved in the administration of RSV immunizations or monoclonal antibodies, protecting them from liability as long as their actions are not grossly negligent or reckless. This provision aims to encourage healthcare providers to participate in the administration of these critical treatments without the fear of legal repercussions, thereby enhancing public health efforts against RSV in young children.